March 2, 2020
2019 Novel Coronavirus (COVID-19)
***Resources***
- Indiana State Department of Health has a hotline set up to help answer questions: 317-233-7125
- Click here to see Indiana’s COVID-19 response page
- Click here to see the CDC response page
Provider and Family Alert: The Indiana State Department of Health (ISDH) is closely monitoring an outbreak of the 2019 novel (new) coronavirus or COVID-19.
This new respiratory virus was first identified in the city of Wuhan in China’s Hubei Province and continues to infect people in China and around the world, including the United States.
ISDH is working with federal and local partners to respond to this evolving public health situation. The Centers for Disease Control and Prevention (CDC) reports that the risk of infection in the United States is low, as the virus has had limited person-to-person spread in the United States at this time. The CDC does not have any evidence to suggest that animals or animal products imported from China pose a risk for spreading COVID-19 in the United States.
Please consult the state’s page for updated news and guidance on the COVID-19 outbreak. Updates will be made as new information becomes available. Please call the ISDH Epidemiology Resource Center at 317-233-7125 [317-233-1325 after hours] or e-mail epiresource@isdh.in.gov if you experience symptoms such as fever, cough and shortness of breath and have a recent history of travel to China or contact with someone suspected of having COVID-19.
Frequently asked questions and answers
- CDC novel coronavirus FAQs
- Frequently Asked Questions About Personal Protective Equipment
- Healthcare Professionals: Frequently Asked Questions and Answers
General novel coronavirus (COVID-19) information and resources
- What you need to know
- Coronavirus Infographic (English)
- Coronavirus Infographic (Spanish)
- Coronavirus Infographic (Chinese)
- 2019 Novel Coronavirus (COVID-19) in the U.S.
- Novel Coronavirus: Prevention steps for close contacts (infographic)
- How COVID-19 spreads
- Information for Travelers
- Preventing 2019 Novel Coronavirus (COVID-2019) from Spreading to Others in Homes and Communities
- Interim Guidance for Businesses and Employers to Plan and Respond to 2019 Novel Coronavirus, February 2020
- Interim Guidance for Colleges and Universities
- Interim Guidance for Administrators of US Childcare Programs and K-12 Schools (new)
- Community Mitigation Guidance: Nonpharmaceutical Interventions for Community Preparedness and Outbreak Response (new)
HEALTH AND SAFETY
Child care programs are more likely to protect children from harm and illness if they consistently practice standards such as frequently washing hands, disinfecting diaper changing stations, cleaning toys and properly storing cleaning supplies and other poisonous materials. Read more…
Information for healthcare professionals
- Novel Coronavirus Case Definition
- CDC Resources for Healthcare Facilities (new)
- For local health departments: Traveler Notification, Risk Assessment and Monitoring Guidance
- Caring for patients with Confirmed or Possible COVID-19 Infection
- Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
- Interim Guidance for Implementing Home Care of People Not Requiring Hospitalization for 2019 Novel Coronavirus (COVID-19) or as infographic
- 2019 Novel Coronavirus Specimen Authorization for Health Care Workers
- Novel Coronavirus (COVID-19) Specimen Authorization Algorithm (updated)
- COVID-19 Checklist for Healthcare Professionals (new)
- Patient Travel Poster (English and Chinese)
- Flowchart to Identify and Assess 2019 Novel Coronavirus
- Healthcare Supply of Personal Protective Equipment
- Interim Considerations for Disposition of Hospitalized Patients with COVID-19 Infection
- Frequently Asked Questions about Respirators and Their Use
- Strategies for Optimizing the Supply of N95 Respirators (updated)
Information for laboratories
- 2019 Novel Coronavirus Specimen Authorization for Health Care Workers
- Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Patients Under Investigation (PUIs) for 2019 Novel Coronavirus (COVID-19)
- Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with 2019 Novel Coronavirus (COVID-19)
- LimsNet Sample Submission
- ISDH Virology Paper Submission
- 10 Things You Should Know about SARS-CoV-2 and COVID-19 (new)
Guidance for healthcare workers and emergency responders
- Interim Infection Prevention and Control Recommendations for Patients Under Investigation for 2019 Novel Coronavirus
- Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
- Interim Guidance of Emerency Medical Services and 911 Public Safety Answering Points for COVID-19 in the U.S.
Page last updated: March 2, 2020